0001104659-23-001900.txt : 20230106
0001104659-23-001900.hdr.sgml : 20230106
20230106170048
ACCESSION NUMBER: 0001104659-23-001900
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230104
FILED AS OF DATE: 20230106
DATE AS OF CHANGE: 20230106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Charney Laurence N
CENTRAL INDEX KEY: 0001407451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32639
FILM NUMBER: 23515767
MAIL ADDRESS:
STREET 1: MARVEL ENTERTAINMENT, INC.
STREET 2: 417 FIFTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TG THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001001316
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 363898269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: (212) 554-4484
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030310
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC
DATE OF NAME CHANGE: 20000330
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960703
4
1
tm232483-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-04
0
0001001316
TG THERAPEUTICS, INC.
TGTX
0001407451
Charney Laurence N
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
1
0
0
0
Common Stock
2023-01-04
4
S
0
30000
11.10
D
234729
D
In connection with the vesting of 100,878 shares on January 1, 2023, 30,000 shares were sold in order to cover the reporting person's income tax obligations.
Reflects the weighted average sale price. The range of prices for the shares sold was $10.91 to $11.38. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Includes shares of restricted Common Stock, which vest over various time periods.
/s/ Laurence N. Charney
2023-01-06